Grifols, S.A. (GRFS)

Healthcare · Drug Manufacturers General · NASDAQ

Grifols, S.A. (GRFS) is a Healthcare company in the Drug Manufacturers General industry. It has a market capitalization of $5.40B, a trailing price-to-earnings ratio of 10.6 and a free-cash-flow yield of 13.3%. Over the most recent reported fiscal year, revenue grew 4.3% and free cash flow per share grew 17.4%.

Market cap	$5.40B
Trailing P/E	10.6
FCF yield	13.3%
Revenue growth (YoY)	+4.3%
EPS growth (YoY)	—
FCF/share growth (YoY)	+17.4%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers General

Explore live GRFS data on Nama Insights →

Recent Congressional trades

Grifols, S.A. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Daniel Goldman	House	Sell	$1,001 - $15,000	Apr 3, 2023
Greg Gianforte	House	Sell	$100,001 - $250,000	Nov 18, 2019
Donna Shalala	House	Sell	$1,001 - $15,000	Jun 30, 2019